Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02153359 · ClinicalTrials.gov registry record · NA
Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02153359: Completed NA study, sponsored by Johns Hopkins University.
NCT02153359 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02153359, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study is about asthma and how the environment affects asthma. Scientists know that air pollution (such as cigarette smoke and other particles in the air) can make asthma symptoms worse. This research is being done to study how the health of a person with asthma responds to an air cleaner. The investigator hypothesize that an air cleaner will improve the health of persons with asthma.
Primary Outcome
Fine particulate matter (PM2.5) concentration as assessed by a passive filter placed in the participant's home.
Interventions
- DEVICE Sham air cleaner
- DEVICE High Efficiency Particulate Air Cleaner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2014-02 |
| Est. Completion | 2018-09-11 |
| Phase | NA |
What the finished NCT02153359 record still lists
NCT02153359 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham air cleaner is the first listed.
NCT02153359 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02153359 about?
NCT02153359 is a clinical study titled "Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response". This study is about asthma and how the environment affects asthma. Scientists know that air pollution (such as cigarette smoke and other particles in the air) can make asthma symptoms worse. This research is being done to study how the health of a person with asthma responds to an air cleaner. The i...
What is the current status of trial NCT02153359?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2014-02. Estimated completion is 2018-09-11.
What interventions are being tested in trial NCT02153359?
The interventions under investigation include: Sham air cleaner (DEVICE), High Efficiency Particulate Air Cleaner (DEVICE).
Who is sponsoring clinical trial NCT02153359?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02153359's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia